Received Apr 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | LL347 | IM / RL |
Patient was given Menveo 1 dose vial presentation which is not indicated for children under age 10. No adverse effects noted.
None
Sickle Cell Disease, Functional Asplenia, Congenital dermal melanocytosis, Annular dermatitis
penicillin V potassium
NKA
None